Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry
Devos, Timothy, Havelange, Violaine, Theunissen, Koen, Meers, Stef, Benghiat, Fleur Samantha, Gadisseur, Alain, Vanstraelen, Gaëtan, Vellemans, Hélène, Bailly, Benjamin, Granacher, Nikki, Lewalle, Philippe, De Becker, Ann, Van Eygen, Koen, Janssen, Mia, Triffet, Agnes, Vrelust, Inge, Deeren, Dries, Mazure, Dominiek, Bekaert, Julie, Beck, Michael, Selleslag, Dominik
Published in Annals of hematology (01.07.2021)
Published in Annals of hematology (01.07.2021)
Get full text
Journal Article
S168: PELABRESIB (CPI‐0610) MONOTHERAPY IN PATIENTS WITH HIGH‐RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY
Passamonti, Francesco, Patriarca, Andrea, Knapper, Steven, Rivera, Candido, Scandura, Joseph M, Devos, Timothy, Granacher, Nikki, Mead, Adam, Oh, Stephen, Palmer, Jeanne, Rampal, Raajit K, Teichmann, Lino, LI, Qing, Eliane, Jean‐Pierre, Chang, Tzuu‐Wang, Klein, Sandra, Colak, Gozde, Harrison, Claire
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions
Granacher, Nikki Charlotta Paul, Berneman, Zwi N, Schroyens, Wilfried, Van de Velde, Ann L R, Verlinden, Anke, Gadisseur, Alain P A
Published in Experimental hematology & oncology (11.04.2017)
Published in Experimental hematology & oncology (11.04.2017)
Get full text
Journal Article
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
Mascarenhas, John, Kremyanskaya, Marina, Patriarca, Andrea, Palandri, Francesca, Devos, Timothy, Passamonti, Francesco, Rampal, Raajit K, Mead, Adam J, Hobbs, Gabriella, Scandura, Joseph M, Talpaz, Moshe, Granacher, Nikki, Somervaille, Tim C P, Hoffman, Ronald, Wondergem, Marielle J, Salama, Mohamed E, Colak, Gozde, Cui, Jike, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M, Verstovsek, Srdan, Curto-García, Natalia, Harrison, Claire, Gupta, Vikas
Published in Journal of clinical oncology (10.11.2023)
Published in Journal of clinical oncology (10.11.2023)
Get full text
Journal Article
Pelabresib (CPI-0610) monotherapy in high-risk essential thrombocythemia refractory or intolerant to hydroxyurea: Preliminary results from MANIFEST study
Passamonti, Francesco, Patriarca, Andrea, Knapper, Steven, Rivera, Candido, Scandura, Joseph, Devos, Timothy, Granacher, Nikki, Mead, Adam J., Oh, Stephen, Palmer, Jeanne M., Rampal, Raajit, Teichmann, Lino, Cui, Jie, Klein, Sandra, Colak, Gozde, Harrison, Claire
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy
Cortes, Jorge E., Saikia, Tapan, Kim, Dong-Wook, Alvarado, Yesid, Nicolini, Franck E., Rathnam, Krishnakumar, Khattry, Navin, Punatar, Sachin, Apperley, Jane F., Charbonnier, Aude, Deininger, Michael, de Lavallade, Hugues, Granacher, Nikki, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Mauro, Michael, Vandenberghe, Peter, Verhoef, Gregor, Whiteley, Andrew R., Nag, Arijit, Apte, Shashikant, Yao, Siu-Long, Inamdar, Sandeep, Dillu, Ruchika Irene, Sreenivasan, Jayasree, Chimote, Geetanjali
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
An Update of Safety and Efficacy Results from Phase 1 Dose-Escalation and Expansion Study of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI), in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Failing Prior TKI Therapies
Cortes, Jorge E., Saikia, Tapan, Kim, Dong-Wook, Alvarado, Yesid, Nicolini, Franck E., Rathnam, Krishnakumar, Khattry, Navin, Apperley, Jane F, Deininger, Michael W., de Lavallade, Hugues, Charbonnier, Aude, Granacher, Nikki, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Mauro, Michael J., Vandenberghe, Peter, Verhoef, Gregor, Whiteley, Andrew R., Nag, Arijit, Radhakrishnan, Vivek S, Apte, Shashikant, Yao, Siu-Long, Inamdar, Sandeep, Sreenivasan, Jayasree, Dillu, Ruchika Irene, Chimote, Geetanjali
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Pelabresib (CPI-0610) Monotherapy in Patients with Myelofibrosis - Update of Clinical and Translational Data from the Ongoing Manifest Trial
Kremyanskaya, Marina, Mascarenhas, John, Palandri, Francesca, Vannucchi, Alessandro, Verstovsek, Srdan, Harrison, Claire N., Bose, Prithviraj, Schiller, Gary J., Rampal, Raajit, Drummond, Mark W., Gupta, Vikas, Patriarca, Andrea, Granacher, Nikki, Scandura, Joseph, Prejzner, Witold, Teichmann, Lino L., Curto-Garcia, Natalia, Hoffman, Ronald, Colak, Gozde, Ren, Zheng, Bobba, Suresh, Cui, Jike, Efuni, Sergey, Talpaz, Moshe
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Phase 1 Trial of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): Activity in CML Chronic Phase Patients Failing TKI Therapies Including Ponatinib
Cortes, Jorge E., Saikia, Tapan, Kim, Dong-Wook, Alvarado, Yesid, Nicolini, Franck E, Khattry, Navin, Rathnam, Krishnakumar, Apperley, Jane, Deininger, Michael W., de Lavallade, Hugues, Charbonnier, Aude, Granacher, Nikki, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Mauro, Michael J., Verhoef, Gregor, Vandenberghe, Peter, Whiteley, Andrew R., Apte, Shashikant, Yao, Siu-Long, Kothekar, Mudgal, Sreenivasan, Jayasree, HV, Bimba, Chimote, Geetanjali
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Phase 1 Trial of K0706, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): In Patients with Chronic Myelogenous Leukemia (CML) and Phildelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Failing ≥ 3 Prior TKI Therapies: Initial Safety and Efficacy
Cortes, Jorge E., Kim, Dong-Wook, Nicolini, Franck E, Saikia, Tapan, Charbonnier, Aude, Apperley, Jane F., Rathnam, Krishna, Deininger, Michael W., De Lavallade, Hugues, Khattry, Navin, Whiteley, Andrew, Mauro, Michael J., Verhoef, Gregor, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Apte, Shashikant, Nikki, Granacher, Yao, Siu-Long, Kothekar, Mudgal, Sreenivasan, Jayasree, HV, Bimba, Chimote, Geetanjali
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Data from a Nationwide Belgian Registry
Devos, Timothy, Havelange, Violaine, Theunissen, Koen, Meers, Stef, Benghiat, Fleur Samantha, Gadisseur, Alain, Vanstraelen, Gaëtan, André, Marc, Bailly, Benjamin, Granacher, Nikki, Lewalle, Philippe, De Becker, Ann, Van Eygen, Koen, Lejeune, Marie, Deeren, Dries, Nifosi, Gianfilippo, Triffet, Agnes, Vrelust, Inge, Bekaert, Julie, Beck, Michael, Selleslag, Dominik
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Gerds, Aaron T, Verstovsek, Srdan, Vannucchi, Alessandro M, Al-Ali, Haifa Kathrin, Lavie, David, Kuykendall, Andrew T, Grosicki, Sebastian, Iurlo, Alessandra, Goh, Yeow Tee, Lazaroiu, Mihaela C, Egyed, Miklos, Fox, Maria Laura, McLornan, Donal, Perkins, Andrew, Yoon, Sung-Soo, Gupta, Vikas, Kiladjian, Jean-Jacques, Granacher, Nikki, Lee, Sung-Eun, Ocroteala, Luminita, Passamonti, Francesco, Harrison, Claire N, Oh, Stephen, Klencke, Barbara J, Yu, Jing, Donahue, Rafe, Kawashima, Jun, Mesa, Ruben
Published in The Lancet. Haematology (01.09.2023)
Published in The Lancet. Haematology (01.09.2023)
Get more information
Journal Article
Poster: MPN-328: Pelabresib (CPI-0610) Improved Anemia Associated with Myelofibrosis: Interim Results from the Ongoing MANIFEST Phase 2 Study
Bose, Prithviraj, Verstovsek, Srdan, Kremyanskaya, Marina, Mascarenhas, John, Talpaz, Moshe, Harrison, Claire, Rampal, Raajit, Patriarca, Andrea, Gupta, Vikas, Granacher, Nikki, Somervaille, Tim, Schiller, Gary, Drummond, Mark, Foltz, Linda, Lambert, Jonathan, Prejzner, Witold, Colak, Gozde, Keller, Patricia, Shao, James, Luptakova, Katarina, Hoffman, Ronald, Vannucchi, Alessandro
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
MPN-328: Pelabresib (CPI-0610) Improved Anemia Associated with Myelofibrosis: Interim Results from the Ongoing MANIFEST Phase 2 Study
Bose, Prithviraj, Verstovsek, Srdan, Kremyanskaya, Marina, Mascarenhas, John, Talpaz, Moshe, Harrison, Claire, Rampai, Raajit, Patriarca, Andrea, Gupta, Vikas, Granacher, Nikki, Somervaille, Tim, Schiller, Gary, Drummond, Mark, Foltz, Linda, Lambert, Jonathan, Prejzner, Witold, Colak, Gozde, Keller, Patricia, Shao, James, Luptakova, Katarina, Hoffman, Ronald, Vannucchi, Alessandro
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
MPN-332: Clinical Benefit of Pelabresib (Cpi-0610) in Combination with Ruxolitinib in JAK Inhibitor Treatment-Naïve Myelofibrosis Patients: Interim Efficacy Subgroup Analysis from Arm 3 of the MANIFEST Phase 2 Study
Gupta, Vikas, Kremyanskaya, Marina, Mascarenhas, John, Palandri, Francesca, Patriarca, Andrea, Devos, Timothy, Harrison, Claire, Passamonti, Francesco, Rampai, Raajit, Mead, Adam, Scandura, Joseph, Hobbs, Gabriela, Talpaz, Moshe, Granacher, Nikki, Somervaille, Tim, Hoffman, Ronald, Bose, Prithviraj, Colak, Gozde, Shao, James, Cui, Jike, Bobba, Suresh, Luptakova, Katarina, Verstovsek, Srdan
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Poster: MPN-332: Clinical Benefit of Pelabresib (Cpi-0610) in Combination with Ruxolitinib in JAK Inhibitor Treatment-Naïve Myelofibrosis Patients: Interim Efficacy Subgroup Analysis from Arm 3 of the MANIFEST Phase 2 Study
Gupta, Vikas, Kremyanskaya, Marina, Mascarenhas, John, Palandri, Francesca, Patriarca, Andrea, Devos, Timothy, Harrison, Claire, Passamonti, Francesco, Rampal, Raajit, Mead, Adam, Scandura, Joseph, Hobbs, Gabriela, Talpaz, Moshe, Granacher, Nikki, Somervaille, Tim, Hoffman, Ronald, Bose, Prithviraj, Colak, Gozde, Shao, James, Cui, Jike, Bobba, Suresh, Luptakova, Katarina, Verstovsek, Srdan
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Severe hypereosinophilia: a case report
Steinfort, Nicky, Granacher, Nikki, Ierssel, Sabrina van, Sabato, Vito, Moorkens, Greta
Published in Acta clinica belgica (English ed. Online) (01.01.2016)
Get full text
Published in Acta clinica belgica (English ed. Online) (01.01.2016)
Journal Article
Declined presentation Dendritic cell vaccination as a post-remission treatment in acute myeloid leukemia
Berneman, Zwi, de Velde, Ann Van, Anguille, Sébastien, Nijs, Griet, Stein, Barbara, Cools, Nathalie, Vermeulen, Katrien, Maes, Marie-Berthe, Willemen, Yannick, Granacher, Nikki, Lammens, Martin, Van Tendeloo, Viggo, Smits, Evelien
Published in Experimental hematology (01.09.2015)
Published in Experimental hematology (01.09.2015)
Get full text
Journal Article